CECOG Announces the Expansion of the TIGER Virtual Transborder Tumorboard Platform,  Welcoming Professor Tanja Cufer as Chief Officer for its Medical Coordination.


Under the impression of the SARS-CoV-2 pandemic, CECOG proudly announces the expansion of its TIGER* Virtual Transborder Tumorboard Platform to a large number of Cancer Centers from the entirety of Europe.

Initially designed as a platform for the safeguarded virtual discussion and presentation of cancer patients, their diagnoses, treatments and resulting side effects, the TIGER Platform has helped to guide oncologists from Central and Southeastern Europe (CEE) in clinical decision making based upon virtual discussions with leading cancer experts during the years 2018 and 2019. Under the impression of the current SARS-CoV-2 pandemic, we consider it timely to not only relaunch, but expand the TIGER platform to an expanded geographic area under the inclusion of oncologists from a large number of Cancer Centers.

CECOG is proud to announce that Professor Tanja Cufer will take over the function as Chief Officer for the Medical Management of the TIGER Virtual Transborder Tumorboard as of January 2021.

Professor Tanja Cufer, M.D. Ph.D. is a highly respected medical oncologist, currently full professor of oncology at the Medical Faculty, University of Ljubljana, Slovenia, and senior councillor at the University Clinic Golnik, Slovenia. She gained her academic degrees at the University of Ljubljana and completed fellowships at the Stanford University, Ca., USA, and The Netherlands Cancer Institute in Amsterdam, The Netherlands.

Professor Cufer’s major scientific interests are breast and lung cancers and the molecular biology of cancer, and she is author or co-author of more than 300 peer-reviewed scientific publications, books and book chapters in the field of oncology.

Professor Cufer served as Chair of  the ASCO International Affairs Committee 2011-2012, has been one of the founders of  the ASCO  International Clinical Trials Workshops and chaired its working group  from 2013 to 2014. Within EORTC, Professor Cufer was Member of the Board 2006-2009 and Chairperson of the Breast Cancer Group 2009-2012. Currently, she is chairing  the ESMO/ASCO global curriculum committee.

Within CECOG, Professor Cufer was instrumental in the generation of the CECOG Thoracic Cancers Academy, was a year-long member of the CECOG Lung Cancer Academy from 2016 until today.

We are proud that Professor Cufer has accepted to become an important part of CECOG as Chief Officer for the Medical Management of the TIGER Virtual Transborder Tumorboard Platform.


*TIGER (reg. TM) was generated by an educational grant from Pfizer Inc.